SynthesisBMC public health2026
Silicosis and silica dust sampling in mineral mining across 30 countries: a systematic review and meta-analysis.
Synthesis in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Silicosis and silica dust sampling in mineral mining across 30 countries: a systematic review and meta-analysis.BMC public health · 2026Pooled it
- Prevalence of chronic respiratory disease symptoms and associated occupational risk factors among certified silicosis patients of Rajasthan.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSilicosis is an irreversible scarring lung disease caused by occupational respirable crystalline silica (RCS) dust exposure. Mineral (noncoal) miners who extract metal, nonmetal, stone, and sand/gravel commodities are at risk for silicosis, but disease prevalence and exposures in these heterogeneous mining sectors are poorly understood. We assessed the global burden of silicosis and existing RCS dust sampling practices in mineral mining.
methodsWe conducted a systematic review of studies published through March 2025 from five online databases, without geographic/language restrictions (PROSPERO CRD420250524573). Studies of mineral miners that reported prevalence or incidence of silicosis on chest imaging were included. We performed meta-analyses using random-effects models for pooled prevalence and subgroup analyses based on commodity, Social-demographic Index (SDI), study period (pre/post-1970), and mine type (underground/surface). We also reviewed published reports on existing RCS sampling practices.
findingsThe search yielded 2,408 potential articles. We included 85 studies (95 publications) for systematic review comprising 57 prevalence studies, six cumulative incidence studies, and 28 studies that reported on RCS sampling in mineral mines. The pooled prevalence of silicosis in 162,449 mineral miners from 26 countries was 17% (95% CI [13%, 22%]), based on low certainty due to high study heterogeneity (I2 = 99.6%). Silicosis prevalence was highest in stone (20%; n = 12 studies), nonmetal (20%; n = 6), and metal (18%; n = 36) miners, with lower prevalence in sand/gravel (3%; n = 2) and mixed commodity miners (6%; n = 3), though studies were few and differences non-significant (p = 0.27). Silicosis was significantly less prevalent in contemporary miners and countries with higher SDI, likely related to improved mining conditions and regulations. In 43,282 miners from four countries, the cumulative incidence of silicosis ranged from 2 to 26%. RCS sampling data from 11 countries included area and personal dust samples using different measurement devices and methodologies, performed under national mandates spanning the 1950s-1990s.
conclusionDespite differences based on country SDI and mining era, silicosis prevalence among mineral miners worldwide is considerable. Country-specific variability in silica dust regulation and control likely contributes to prevalence, and future efforts should focus on linking exposure monitoring with policy and medical surveillance to reduce rates of this disabling but preventable disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.